NGS brings power and potential to molecular analysis of urine specimens

Next-generation DNA sequencing can identify more than 50,000 microorganisms.

Nadofaragene firadenovec published data show strong efficacy in BCG-unresponsive NMIBC

“These data published in the Lancet Oncology show that nadofaragene firadenovec, a first-of-its-kind therapy, may be an effective treatment option for BCG-unresponsive non-muscle invasive bladder cancer patients,” Colin P. N. Dinney, MD.

Mirabegron may improve erectile dysfunction in men with overactive bladder symptoms

The findings support continued investigation of the safety and efficacy of mirabegron in men with OAB and concurrent ED, says study author Arthur L. Burnett, II, MD, MBA.